Novo Nordisk: Stock Plunges, But It May Be Time To Load Up
Novo Nordisk faces formidable challenges from Eli Lilly and new rivals, but its first-mover advantage and expanded ...
Billionaire Ken Griffin More Than Doubled His Stake In This Market-Beating Growth Stock
"Billionaire" and "successful hedge fund manager" are titles that carry significant weight on Wall Street. These and others ...
Lily Collins Fans Make Bold Statement About 'Snow White' Movie Decades Later
Amid the ongoing controversy about Disney's live-action remake, fans have resurfaced Collins' 2012 comedy 'Mirror, Mirror.' ...
Donald Trump’s $1.4 trillion tariff threats scramble business plans, US companies form task-forces to tackle impact
Companies in the US, including Novo Nordisk, Boeing and Shein, are forming task forces to address the impact of Donald ...
AbbVie Is Preparing To Challenge Eli Lilly And Novo Nordisk
AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.
ProQR Therapeutics N.V.: ProQR Announces Year End 2024 Operating and Financial Results
Axiomer ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Company expect ...